Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Elevai Labs, Inc. - Common Stock (NQ: ELAB )

0.6310 -0.0193 (-2.97%)
Streaming Delayed Price Updated: 3:59 PM EDT, May 14, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 90,112
Open 0.6499
Bid (Size) 0.6330 (10)
Ask (Size) 0.6500 (2)
Prev. Close 0.6503
Today's Range 0.6301 - 0.6503
52wk Range 0.5709 - 4.244
Shares Outstanding N/A
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Elevai Biosciences Highlights Preclinical Data Showing Potential of In-Licensed Asset “EL-22” for The Treatment of Obesity
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Wednesday's After-Market Session
Via Benzinga

Performance

YTD
-66.61%
-66.61%
1 Month
+9.74%
+9.74%
3 Month
-1.41%
-1.41%
6 Month
-81.44%
-81.44%
1 Year
-81.44%
-81.44%

More News

Read More
Elevai Labs Expands with Launch of Elevai Biosciences and Elevai Skincare Subsidiaries, Advancing the Future of Aesthetic Medicines and Exosome Skincare
From Elevai Labs Inc.
Via GlobeNewswire
ELAB Stock Earnings: Elevai Labs Reported Results for Q4 2023
Via InvestorPlace
Elevai Labs Acquires Exclusive License to Two Myostatin Muscle Loss Prevention Assets with Plan to Develop in Combination with GLP-1 Obesity Treatments
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Highlights Global Distribution Partnership Overview: Contracts May Secure $4.9M Top Line Revenue Commitments
From Elevai Labs Inc.
Via GlobeNewswire
ELEVAI Labs Enters the Taiwan Market with Signing of 5th International Distribution Agreement in 14 Months
From Elevai Labs Inc.
Via GlobeNewswire
12 Consumer Staples Stocks Moving In Tuesday's After-Market Session
Via Benzinga
Elevai Labs Inc. Reports Record Full Year 2023 and Fourth Quarter Financial Results
From Elevai Labs Inc.
Via GlobeNewswire
Elevai Labs Launches E-commerce Portal to Support Rapid Growth as Stem Cell Exosome Disruptor in the $19.7 Billion Global Physician Dispensed Cosmeceutical Market
From Elevai Labs Inc.
Via GlobeNewswire
Why NVIDIA Shares Are Trading Higher By Around 14%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
Why Palantir Technologies Shares Are Trading Higher By 18%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why C.H. Robinson Shares Are Trading Lower By Over 12%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
Via Benzinga
Why Is Revelation Biosciences (REVB) Stock Down 62% Today?
Via InvestorPlace
Why Is Kiora Pharmaceuticals (KPRX) Stock Up 39% Today?
Via InvestorPlace
Why Is Elevai Labs (ELAB) Stock Up 57% Today?
Via InvestorPlace
Why Nextracker Shares Are Trading Higher By Around 20%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
Via InvestorPlace
ELEVAI Labs Inc. Announces Issuance of Patent from U.S. Patent & Trademark Office
From Elevai Labs Inc.
Via GlobeNewswire
Top 4 Defensive Stocks That Could Lead To Your Biggest Gains In January
Via Benzinga
ELEVAI LABS, Inc. Reports Strong Preliminary Unaudited Financial Performance for Fiscal Year 2023, Highlighting Significant Revenue Growth and Expanding Global Reach
From Elevai Labs Inc.
Via GlobeNewswire
Why DatChat Shares Are Trading Lower By Around 33%; Here Are 20 Stocks Moving Premarket
Via Benzinga
Why Is Elevai Labs (ELAB) Stock Up Today?
Via InvestorPlace
Why Elevai Labs Stock Is Trading Higher
Via Benzinga
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.